Novel Lipid Species for Detecting and Predicting Atrial Fibrillation in Patients With Type 2 Diabetes
Article Information
vol. 70 no. 1 255-261
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 22, 2020
- Accepted October 15, 2020
- Published in print December 21, 2020.
- Published online ahead of print October 28, 2020.
Article Versions
- Previous version (October 28, 2020 - 15:36).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.
Author Information
- Yow Keat Tham1,2,
- Kaushala S. Jayawardana1,
- Zahir H. Alshehry1,3,
- Corey Giles1,
- Kevin Huynh1,
- Adam Alexander T. Smith1,
- Jenny Y.Y. Ooi1,2,
- Sophia Zoungas4,5,
- Graham S. Hillis4,6,
- John Chalmers4,
- Peter J. Meikle1,2,3⇑ and
- Julie R. McMullen1,2,7,8⇑
- 1Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
- 2Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia
- 3Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia
- 4The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia
- 5School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
- 6Royal Perth Hospital/University of Western Australia, Perth, Western Australia, Australia
- 7Department of Physiology, Monash University, Clayton, Victoria, Australia
- 8Department of Physiology, Anatomy and Microbiology, La Trobe University, Bundoora, Victoria, Australia
- Corresponding author: Julie R. McMullen, julie.mcmullen{at}baker.edu.au, or Peter J. Meikle, peter.meikle{at}baker.edu.au